Power Morcellators Increase Undetected Cancers Levels
By HospiMedica International staff writers Posted on 04 Aug 2014 |
A new study shows that using power morcellators in women undergoing laparoscopic hysterectomy results in increased levels of undetected cancer.
Researchers at the Columbia University College of Physicians and Surgeons (New York, NY, USA) conducted a study involving 36,470 women who underwent minimally invasive hysterectomy with uterine morcellation between 2006 and 2012, in more than 500 hospitals. The primary outcome was identification of uterine corpus cancer (all histologies) based on the International Classification of Diseases. The researchers also examined the occurrence of uterine neoplasms; malignancies of other parts of the uterus, including cervical cancer and surrounding adnexal structures (other gynecologic cancer); and endometrial hyperplasia.
The results showed that among those who underwent morcellation, 99 cases of uterine cancer were identified; 26 cases of other gynecologic malignancies were also found, as were 39 uterine neoplasms of uncertain malignant potential, and 368 cases of endometrial hyperplasia. Among women who underwent morcellation, advanced age was associated with underlying cancer and endometrial hyperplasia. Compared with women younger than 40 years, the prevalence ratio for a uterine malignancy increased from 4.97 in women aged 50 to 54 years, to 19.37 in those aged 55 to 59 years, to 21.36 in those aged 60 to 64 years, and to 35.97 for women aged 65 years or older. The study was published on July 22, 2014, in the Journal of the American Medical Association (JAMA).
“ Women with apparent uterine-confined neoplasms at the time of morcellation have been found to have intraperitoneal tumor dissemination at the time of re-exploration,” concluded lead author Jason Wright, MD, and colleagues. “Although morcellators have been in use since 1993, few studies have described the prevalence of unexpected pathology at the time of hysterectomy. Patients considering morcellation should be adequately counseled about the prevalence of cancerous and precancerous conditions prior to undergoing the procedure.”
Even though MIS has improved outcomes for hysterectomy, the procedure requires removal of the uterus through small incisions. This has led to morcellation—fragmentation of the uterus into smaller pieces—into one such method to remove the uterus. In May 2014, the US Food and Drug Administration (FDA) issued a warning against using laparoscopic "power morcellator" devices in MIS to remove uterine fibroids, claiming that women undergoing the procedures carried a 1 in 350 risk of uterine sarcoma, and that morcellator tools could worsen the spread of cancerous tissue.
Related Links:
Columbia University College of Physicians and Surgeons
Researchers at the Columbia University College of Physicians and Surgeons (New York, NY, USA) conducted a study involving 36,470 women who underwent minimally invasive hysterectomy with uterine morcellation between 2006 and 2012, in more than 500 hospitals. The primary outcome was identification of uterine corpus cancer (all histologies) based on the International Classification of Diseases. The researchers also examined the occurrence of uterine neoplasms; malignancies of other parts of the uterus, including cervical cancer and surrounding adnexal structures (other gynecologic cancer); and endometrial hyperplasia.
The results showed that among those who underwent morcellation, 99 cases of uterine cancer were identified; 26 cases of other gynecologic malignancies were also found, as were 39 uterine neoplasms of uncertain malignant potential, and 368 cases of endometrial hyperplasia. Among women who underwent morcellation, advanced age was associated with underlying cancer and endometrial hyperplasia. Compared with women younger than 40 years, the prevalence ratio for a uterine malignancy increased from 4.97 in women aged 50 to 54 years, to 19.37 in those aged 55 to 59 years, to 21.36 in those aged 60 to 64 years, and to 35.97 for women aged 65 years or older. The study was published on July 22, 2014, in the Journal of the American Medical Association (JAMA).
“ Women with apparent uterine-confined neoplasms at the time of morcellation have been found to have intraperitoneal tumor dissemination at the time of re-exploration,” concluded lead author Jason Wright, MD, and colleagues. “Although morcellators have been in use since 1993, few studies have described the prevalence of unexpected pathology at the time of hysterectomy. Patients considering morcellation should be adequately counseled about the prevalence of cancerous and precancerous conditions prior to undergoing the procedure.”
Even though MIS has improved outcomes for hysterectomy, the procedure requires removal of the uterus through small incisions. This has led to morcellation—fragmentation of the uterus into smaller pieces—into one such method to remove the uterus. In May 2014, the US Food and Drug Administration (FDA) issued a warning against using laparoscopic "power morcellator" devices in MIS to remove uterine fibroids, claiming that women undergoing the procedures carried a 1 in 350 risk of uterine sarcoma, and that morcellator tools could worsen the spread of cancerous tissue.
Related Links:
Columbia University College of Physicians and Surgeons
Latest Surgical Techniques News
- Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health
- Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery